Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FENSH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,255
Award facts
- Contract value 100% obligated
- $4,255.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $4,255.34 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on November 18, 2025, falls under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply across the Department of Defense. DMS Pharmaceutical Group was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The vendor supplies a comprehensive range of pharmaceutical products including branded and generic prescription medications, specialty pharmaceuticals, biologics, vaccines, and medical consumables to support military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency (contract SPE2DR), which was awarded on November 13, 2025, with a $499,999,999 ceiling and completion date of December 31, 2036. The underlying IDC includes a 30-month base period with three 30-month option periods, positioning DMS Pharmaceutical Group as one of multiple regional prime vendor contractors within the PPV-G GEN V framework. The company's established performance across numerous recent delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system globally, with no identified subcontractors on this award.
Quick answers
Who was awarded contract SPE2DU26FENSH?
SPE2DU26FENSH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DU26FENSH worth?
The government has obligated $4,255 on SPE2DU26FENSH.
Is contract SPE2DU26FENSH an order under another contract?
Yes. SPE2DU26FENSH is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENSH competed?
The extent of competition for SPE2DU26FENSH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award